## AJCC 8th Edition Melanoma Staging **Key Point:** Melanoma staging integrates Breslow thickness, ulceration status, mitotic rate, and nodal/distant metastasis status. The presence of sentinel lymph node involvement determines Stage III classification. ### Prognostic Factors in This Case | Factor | Finding | Significance | |--------|---------|---------------| | **Breslow thickness** | 2.8 mm | T3 (1.01–4.0 mm) | | **Ulceration** | Absent | Favorable | | **Mitotic rate** | 3/mm² | Present (≥1/mm²) | | **Sentinel lymph node** | Negative | N0 (no nodal involvement) | | **Distant metastasis** | None | M0 | ### Stage Assignment Logic 1. **T stage:** Breslow 2.8 mm = T3 (thickness 1.01–4.0 mm without ulceration) 2. **N stage:** Negative sentinel lymph node biopsy = N0 3. **M stage:** No distant metastases = M0 4. **Stage determination:** T3, N0, M0 = **Stage IIB** **High-Yield:** The presence of mitotic rate ≥1/mm² in a non-ulcerated lesion 1.01–4.0 mm thick places this in Stage IIB (not Stage IIA, which requires either ulceration OR thickness 0.8–1.0 mm). **Clinical Pearl:** Sentinel lymph node biopsy is recommended for melanomas ≥0.8 mm thick or with high-risk features (ulceration, high mitotic rate, young age). Negative SLNB confirms N0 status and excludes Stage III disease. **Mnemonic: AJCC T-Staging for Melanoma** - T1: ≤0.8 mm - T2: 0.81–1.0 mm - T3: 1.01–4.0 mm - T4: >4.0 mm (Presence of ulceration or mitotic rate ≥1/mm² upstages within the same thickness category in earlier editions; AJCC 8e uses thickness primarily.) [cite:AJCC Cancer Staging Manual 8th Edition] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.